Publicaciones en las que colabora con Javier Santos Vicente (22)

2024

  1. Characterization of Immune Cell Populations and Acid-Sensing Receptors in the Human Esophagus

    Gastroenterology Insights, Vol. 15, Núm. 3, pp. 819-834

2023

  1. Acute Stress Regulates Sex-Related Molecular Responses in the Human Jejunal Mucosa: Implications for Irritable Bowel Syndrome

    Cells, Vol. 12, Núm. 3

  2. Acute psychological stress increases paracellular permeability and modulates immune activity in rectal mucosa of healthy volunteers

    United European Gastroenterology Journal, Vol. 11, Núm. 1, pp. 31-41

  3. Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants

    Journal of Translational Medicine, Vol. 21, Núm. 1

  4. Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery

    Frontiers in Immunology, Vol. 14

2022

  1. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations

    Cells, Vol. 11, Núm. 13

2021

  1. Present and Future Therapeutic Approaches to Barrier Dysfunction

    Frontiers in Nutrition, Vol. 8

  2. The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults

    Advances in Therapy, Vol. 38, Núm. 5, pp. 2054-2076

2020

  1. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome

    Scientific Reports, Vol. 10, Núm. 1

  2. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

    The American journal of gastroenterology, Vol. 115, Núm. 12, pp. 2047-2059

2019

  1. Intestinal mucosal mast cells: Key modulators of barrier function and homeostasis

    Cells, Vol. 8, Núm. 2

2018

  1. Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study

    United European Gastroenterology Journal, Vol. 5, Núm. 6, pp. 887-897

  2. MiR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea

    Gut, Vol. 66, Núm. 9, pp. 1597-1610

  3. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome

    Journal of Gastroenterology and Hepatology (Australia), Vol. 32, Núm. 1, pp. 53-63

2015

  1. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations

    Gut, Vol. 64, Núm. 9, pp. 1379-1388

2013

  1. Diarrhoea-predominant irritable bowel syndrome: An organic disorder with structural abnormalities in the jejunal epithelial barrier

    Gut, Vol. 62, Núm. 8, pp. 1160-1168

2012

  1. Acute experimental stress evokes a differential gender-determined increase in human intestinal macromolecular permeability

    Neurogastroenterology and Motility, Vol. 24, Núm. 8

  2. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome

    Gut and Liver, Vol. 6, Núm. 3, pp. 305-315

  3. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction

    Psychoneuroendocrinology, Vol. 37, Núm. 1, pp. 65-77